EAU 2014 - Poster: Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase and prostate-specific antigen in patients with castration-resistant prostate cancer and symptomatic bone metastases from the phase 3 ALSYMPCA trial

STOCKHOLM, SWEDEN (UroToday.com) - Presented by D. Heinrich,1 C. Parker,2 M. Shan,3 S. Wilhelm,3 M. Wahba,3 J. Garcia-Vargas,3 C.G. O’Bryan-Tear,4 O. Sartor5 at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

Heinrich EAU 2014 thumb

1Akershus University Hospital, Lørenskog, Norway; 2The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK; 3Bayer HealthCare, Whippany, NJ, USA; 4Algeta ASA, Oslo, Norway; 5Tulane University Cancer Center, New Orleans, LA, USA

Click HERE to read an exclusive report by a UroToday medical writer

 

email news signup